COVID-19

Clinical impact of COVID-19 on patients with cancer treated with immune checkpoint inhibition
Aljosja Rogiers, Ines Pires da Silva, Chiara Tentori, Carlo Alberto Tondini, Joseph M Grimes, Megan H Trager, Sharon Nahm, Leyre Zubiri, Michael Manos, Peter Bowling, Arielle Elkrief, Neha Papneja, Maria Grazia Vitale, April A N Rose, Jessica S W Borgers, Severine Roy, Joanna Mangana, Thiago Pimentel Muniz, Tim Cooksley, Jeremy Lupu, Alon Vaisman, Samuel D Saibil, Marcus O Butler, Alexander M Menzies, Matteo S Carlino, Michael Erdmann, Carola Berking, Lisa Zimmer, Dirk Schadendorf, Laura Pala, Paola Queirolo, Christian Posch, Axel Hauschild, Reinhard Dummer, John Haanen, Christian U Blank, Caroline Robert, Ryan J Sullivan, Paolo Antonio Ascierto, Wilson H Miller Jr, F Stephen Hodi, Karijn P M Suijkerbuijk, Kerry L Reynolds, Osama E Rahma, Paul C Lorigan, Richard D Carvajal, Serigne Lo, Mario Mandala, Georgina V Long

Journal for ImmunoTherapy of Cancer Jan 2021, 9 (1) e001931; DOI: 10.1136/jitc-2020-001931
Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management
Jennifer L Marté, Nicole J Toney, Lisa Cordes, Jeffrey Schlom, Renee N Donahue, James L Gulley

Journal for ImmunoTherapy of Cancer Nov 2020, 8 (2) e001019; DOI: 10.1136/jitc-2020-001019
Clinical activity of pembrolizumab in metastatic prostate cancer with microsatellite instability high (MSI-H) detected by circulating tumor DNA
Pedro Barata, Neeraj Agarwal, Roberto Nussenzveig, Benjamin Gerendash, Ellen Jaeger, Whitley Hatton, Elisa Ledet, Brian Lewis, Jodi Layton, Hani Babiker, Alan Bryce, Rohan Garje, Cy Stein, Lesli Kiedrowski, Philip Saylor, Oliver Sartor

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e001065; DOI: 10.1136/jitc-2020-001065
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy
Vincenzo Montesarchio, Roberto Parrella, Chiara Iommelli, Antonella Bianco, Elio Manzillo, Fiorentino Fraganza, Cristiana Palumbo, Gaetano Rea, Patrizia Murino, Rosanna De Rosa, Luigi Atripaldi, Maurizio D’Abbraccio, Marcello Curvietto, Domenico Mallardo, Egidio Celentano, Antonio Maria Grimaldi, Marco Palla, Claudia Trojaniello, Maria Grazia Vitale, Samuel Lewis Million-Weaver, Paolo Antonio Ascierto

Journal for ImmunoTherapy of Cancer Aug 2020, 8 (2) e001089; DOI: 10.1136/jitc-2020-001089
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity
Jia Wei, Jianping Zhao, Meifang Han, Fankai Meng, Jianfeng Zhou

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e000862; DOI: 10.1136/jitc-2020-000862
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment
Ernesto Rossi, Giovanni Schinzari, Giampaolo Tortora

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e000952; DOI: 10.1136/jitc-2020-000952
ACE2 and TMPRSS2 expression by clinical, HLA, immune, and microbial correlates across 34 human cancers and matched normal tissues: implications for SARS-CoV-2 COVID-19
Riyue Bao, Kyle Hernandez, Lei Huang, Jason John Luke

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e001020; DOI: 10.1136/jitc-2020-001020
BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy
Madhuri Koti, Alvaro Morales, Charles H Graham, David Robert Siemens

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e001119; DOI: 10.1136/jitc-2020-001119
On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19
Thilo Gambichler, Judith Reuther, Christina H Scheel, Jürgen Christian Becker

Journal for ImmunoTherapy of Cancer Jul 2020, 8 (2) e001145; DOI: 10.1136/jitc-2020-001145
Randomized phase II study of stereotactic body radiotherapy and interleukin-2 versus interleukin-2 in patients with metastatic melanoma
Brendan Curti, Marka Crittenden, Steven K Seung, Christopher B Fountain, Roxanne Payne, ShuChing Chang, Jessica Fleser, Kimberly Phillips, Ian Malkasian, Lyn B Dobrunick, Walter J Urba

Journal for ImmunoTherapy of Cancer May 2020, 8 (1) e000773; DOI: 10.1136/jitc-2020-000773

Main menu

COVID-19

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

COVID-19

Pages